Flywheel for

Flywheel’s imaging data management and analysis platform is purpose-built for biopharma companies like Boehringer Ingelheim who are conducting multisite respiratory, ophthalmology and neurology programs, helping accelerate drug development, AI and research workflows

We’re working with 10 of the top 20 biopharma companies to ensure they maximize the value of their imaging data for secondary endpoint analysis, biomarker extraction, and faster clinical trial decisions. Connect with our experts to explore how your team can:

Learn how Boehringer Ingelheim could benefit from a validated imaging platform that supports tens of thousands of researchers with faster insights into ongoing clinical trials and reproducible, AI-ready data pipelines.

Fill out the form and we’ll reach out within 1 business day.